Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 62.37 | N/A |
PEG Ratio (TTM) | -2.42 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 2.47 | N/A |
P/FCF Ratio (TTM) | -2,092.73 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.28% | N/A |
ROE (TTM) | 3.06% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -10.75% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -14.36% | N/A | N/A |
Cash Flow | -70.39% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.00 | N/A |
Quick Ratio (TTM) | 0.00 | N/A |
D/E Ratio (TTM) | 0.06 | N/A |
Interest Coverage (TTM) | -0.79 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 5.63 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |